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ABSTRACT A specific antibody against myosin light chain kinase (MLCK) was used to identify 
the presence of a Ca2+-calmodulin-activated MLCK in mouse T-lymphoma cells. With a double 
immunofluorescence t chnique, MLCK was determined to be accumulated directly under Con 
A-capped structures in a manner similar to that of previously described accumulation of 
actomyosin. The lymphocyte MLCK was phosphorylated in the uncapped cell and, by immu- 
noprecipitation with a specific MLCK antibody, was shown to possess a Mr of 130,000. The 
MLCK was also found to constitute a major fraction of the phosphoproteins present in the 
plasma membrane associated-cytoskeleton. Myosin light chain kinase catalyzed the phospho- 
rylation of both endogenous lymphocyte myosin light chains and those from smooth and 
skeletal muscle. The enzyme activity was dependent on the presence of Ca2+-calmodulin and 
was inhibited by the calmodulin-binding drug, trifluoperazine. These data suggest that the 
membrane-cytoskeleton-associated MLCK activity may be important in regulation of the actin- 
myosin contraction which is believed to be required for the collection of surface receptors into 
capped structures. 
Lymphocyte surface receptors will aggregate into a cap struc- 
ture at one pole of the cell in an energy- and temperature- 
dependent manner upon the addition of external multivalent 
ligands such as lectins or antibodies (32, 33). Cytochemically, 
it has been shown that intracellular actin and myosin are 
always concentrated underneath e cap (4-6). Several research 
groups have detected biochemicaUy the existence of an acto- 
myosin-containing cytoskeleton i the receptor-cap structures 
(12, 16, 23). Therefore, it has been proposed that transmem- 
brane linkages occur between the actomyosin filaments and 
the surface receptors that are required for the clustering of the 
surface receptors into caps via a sliding filament mechanism 
analogous to that occurring during muscle contraction (4). 
Studies on both smooth muscle and nonmuscle cells indicate 
that actomyosin-mediated contraction is regulated by myosin 
light chain kinase which in turn is regulated by Ca2+-calmod- 
ulin (3, 14). In addition, the phosphorylation f myosin light 
chain has been shown to enhance the actin-activated Mg ++- 
ATPase of myosin which produces the energy to drive the 
sliding filament contraction process (1, 30). In what might be 
an analogous mechanism, the 20,000-dalton myosin light chain 
in lymphocytes i  phosphorylated during surface receptor cap- 
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ping (9). It has also been shown recently that the capping 
process can be inhibited (7) by a drug, trifluoperazine (TFP or 
Stelazine), that binds to calmodulin in a Ca2+-dependent man- 
ner. Finally, the process is also directly regulated in vitro by 
micromolar concentrations of Ca 2+ ion (10). Together, these 
observations support he contention that this nonmuscle con- 
tractile process is myosin light chain kinase-dependent (3). 
Using an immunocytochemical method, we found that 
myosin light chain kinase (MLCK) is accumulated preferen- 
tially under Concanavalin A (Con A)-induced caps. The lym- 
phocyte light chain kinase (MLCK) is associated with the 
plasma membrane-derived actomyosin-containing cytoskele- 
ton. The identity of this enzyme has been assured by immu- 
noprecipitation of a :~2P-labeled 130,000-Mr protein with a 
specific MLCK antibody and the capability of the enzyme to 
catalyse the calmodulin-dependent phosphorylation f endog- 
enous lymphocyte, as well as exogenous smooth and skeletal 
muscle myosin light chains. Consequently, we are proposing 
that the MLCK-mediated phosphorylation of myosin light 
chain in response to Ca2+-calmodulin is one mechanism re- 
sponsible for the activation of contractile lements required for 
the aggregation of receptors into capped structures. 
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MATERIALS AND METHODS 
Cells 
The mouse T-lymphoma cell line, AKR/J lymphoma cell line BW5147 (gift 
from Dr. R. Hyman, The Salk Institute), was grown in Dulbecco's modified 
Eagle's (DME) medium supplemented with 10% heat-inactivated horse serum 
(Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) at 37°C 
in 5% CO2/95% air. 
A n tibodies 
Rabbit anti-chicken gizzard MLCK and rabbit anti-human uterus smooth 
muscle myosin were prepared according to the procedures described previously 
(19, 30. 
Induction of Capping by Fluorescein-conjugated 
Concanavalin A (FI-Con A) 
Cells stained for their initial surface Con-A distribution were first washed with 
DME and fixed with 2% paraformaldehyde in 0.1 M PBS (pH 7.4) for 30 min at 
0°C. Both prefixed and unfixed cell suspensions (~1 x l07 cells/ml) were 
incubated with Fl-Con A (50 pg/m[) at 0°C for 30 rain. Unbound F1-Con A was 
subsequently removed by rinsing, and cells were incubated at room temperature 
for 15 rain. In the case of prefixed cells, Con-A receptors were immobilized (Fig. 
I a), and unfixed ceils displayed a typical cap structure (Fig. I c). 
Drug Effect on Surface Con A Capping 
Unfixed cell suspensions (1 X I07 cells/ml) were preincubated with 5 x 10 -~ 
M of trifluoperazine dihydrochloride (TFP) (Stelazine, Smith Kline and French 
Laboratories, Philadelphia, PA) (25, 26) for 30 min at room temperature. Drug- 
treated cells were subjected to the induction of Con-A capping as described 
above. 
anti-chicken gizzard MLCK (100 #g/ml) followed by rhodamine-conjugated goat 
antibody against rabbit immunoglobulin. As a control, preabsorbed anti-MLCK- 
free immunoglobulin was used instead of anti-MLCK antibodies. No MLCK 
staining was detected in the control samples. 
The flourescein- and rhodamine-labeled samples were examined in a Zeiss 
photomicroscope with a x 40 oil immersion lens and an epiilluminator. Fluores- 
cein and rhodamine fluorescences were excited with an Osram HBO 50-W bulb 
using filter combination CZ487710 and CZ 487714, respectively. Ceils were 
photographed with Kodak Plus-x film. 
Radioactive Labeling for 
Cellular Phosphoproteins 
Cel/suspensions (1 x 106 cells/ml) were washed with phosphate-free DME 
and labeled with 0.1 mCi 32p (Hs32po4, carrier free, ICN) for 30 rain at room 
temperature. Phosphorylation was terminated by adding an excess (10 vol) of 
unlabeled 0.1 M PBS at 0°C. 
Plasma Membrane Isolation 
Plasma membrane fractions were isolated by the method escribed by Johnson 
and Bourne (20). 32P-labeled cells were washed twice with Dulbecco's phosphate- 
buffer medium and resuspended ata density of 107 cells/ml in 20 mM HEPES, 
2 mM MgCI~, 1 mM EDTA, 1 mM 2-mercaptoethanol, pH 7.4, at 4°C. Ceils 
were disrupted with a Dounce homogenizer. The lysate was centrifuged at 750 
g,~ for 5 min and the supernatant fluid was centrifuged in an SW50.1 rotor 
(Beckman Instruments, Inc., Palo Alto, CA) at 43,000 g,v for 20 min. The pellet 
was resuspended in 10"7o sucrose (wt/wt) in the same buffer and centrifuged in a 
Beckman SW 50.1 rotor at 100,000 ga~ for 80 rain. The plasma membrane 
fraction, which sediments between 30% and 40% sucrose, was collected and 
washed with Dulbecco's PBS. Surface markers uch as T200, Thy-1, and glyco- 
protein (gp) 69/71 have been reported to be preferentially concentrated in this 
particular plasma embrane fraction by immunoprecipitation techniques (8). 
Double Immunofluorescence Microscopy 
Both capped and uncapped cells were rendered permeable by using either 
frozen sections (5) or methanol/acetone tr atment (11) and stained with rabbit 
Nonidet P-40 (NP-40) Extraction 
The isolated plasma membranes (with or without :~P-labeling) were first 
resuspended in PPI solution (10 mM sodium phosphate buffer, pH 7.2, containing 
I mM phenylmethylsulphonyl fluoride (PMSF), and 10 mM iodoacetamide). 
Nonionic detergent extraction was carried out according to the procedures 
described previously (27) by adding 1% NP-40 to the plasma membrane pr pa- 
ration in PPI solution with vigorous vortexing. Protein concentration was held 
constant at 0.5 mg/ml. The samples were incubated at 0°C for 20 min with 
frequent vortexing and then centrifuged for 45 rain at 100,000 gay. After centrif- 
ugation, the pellets (i.e., NP-40-insoluble fraction) were collected for further 
biochemical nd cytochemical nalysis. 
FIGURE 1 Simultaneous localization of surface Con-A receptors 
and intracellular MLCK. (a-b) Prefixed cells stained with FI-Con A 
(a) followed by either frozen thick sectioning or acetone treatment 
and rabbit anti-MLCK plus rhodamine (Rh)-goat anti-rabbit immu- 
noglobulin, a shows FI-Con A staining of the same cell stained for 
MLCK in b. (c-d) Unfixed cells were induced to form cap by 
treatment with FI-Con A (c) followed by staining with rabbit anti- 
MLCK plus Rh-goat anti-rabbit immunoglobulin as described above 
(d). c shows the Con A cap on the same cell stained for MLCK as 
shown in d. (e- f )  In the presence of TFP (Stelazine), cells were 
treated with FI-Con A (e) followed by labeling with rabbit anti- 
MLCK and Rh-goat anti-rabbit immunoglobulin ( f )  as mentioned 
above, e represents the FI-Con A staining on the same cell labeled 
for MLCK as shown in f. (a-f) X 1,500. 
Imm unoprecipita tion 
~'zP-labeled total plasma membranes or cytosk¢letal fractions isolated from 
uncapped cells (l × 10 a ceils) were incubated with 0.1% NP-40 in 10 mM Tris- 
HCL pH 8.0, at 4°C for 30 rain. The NP-40-treated membrane or cytoskeletal 
fractions were then incubated with either rabbit anti-MLCK or anti-MLCK-free 
(preabsorbed) antisera (100 pg/ml) at 4°C for 30 min. Subsequently, goat anti- 
rabbit immunoglobulin (200 ~g/ml) was added to the samples at 4°C for 30 rain 
to precipitate the immune complex. The immunoprecipitates were obtained by 
cantrifugation at 12,000 gay for 10 rain. Each precipitate was washed with PBS 
three times using the same centrifugation procedure. The polypeptide composition 
and radioactivity of the immunoprecipitates w re determined by SDS PAGE and 
autoradiography, respectively. 
SDS PAGE and Radioactivity Analysis 
Electrophoresis was carried out on slab gels using the discontinuous buffer 
system described by Laemmli (24) and an exponential polyacrylamide g l gra- 
dient (7.0-17.5%) (21). All radioactively labeled samples (including total plasma 
membranes, NP-40 insoluble fractions of plasma membranes i olated from '~P- 
labeled cells and asP-labeled immunoprecipitates) were dissolved in a buffer 
containing 2% SDS, 0.1 M dithiothreitol, 0.003% bromophenol b ue, 20 mM Tris- 
HC1, pH 6.8, and heated at 100°C for 2 min. Approximately 125 pg of protein 
per sample was applied to the gel. Electrophoresis was c rried out-at a constant 
current of 2 mA for 18 h at room temperature, and the polypeptide banding 
pattern was revealed by staining with Coomassie Blue. The gels were then dried 
by vacuum, and the 32P-labeled ried gels were exposed to Kodak x-ray (X- 
Omat, XR-1) film. 
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Assay of MLCK Activity 
The MLCK-assay procedures used in this study were generally thesame as 
those described previously (19). The reaction mixture contained crude enzyme 
preparations (such as total lymphoma plasma membranes or NP-40 insoluble 
cytoskeletal material), 20 mM KC1, 1 mM Mg acetate, 10 -4 M Ca 2÷ (pCa = 
-loglol0 -4 = 4.0, high Ca2÷), with or without he addition of myosin fight chains 
(e.g., 18 mg/ml chicken gizzard myosin light chains or skeletal myosin light 
chains), 5 #M calmodulin, and 1 mM y-32P-ATP (100-200 cpm/pmol). As 
controls, calmodulin was eliminated and 10 -4 M Ca 2÷ (pCa = 4.0, high Ca 2÷) 
was replaced by 10 -a M Ca ~÷ (pCa = -loglol0 a = 8.0, low Ca 2+) in the reaction 
mixture. In some cases, the enzyme assays were carried out in the presence of 5 
× 10 -~ M trifluoperazine (TFP, Stelazine). Reactions were initiated by the 
addition of "/-32P-ATP (1CN Chemical and Radioisotope Division, lrvine, CA) 
and incubated for 5 min at 30°C. Myosin light chain phosphorylation was 
assayed by the following three methods: (a) spotting 0.005 ml of reaction mixture 
on Whatman 31 ET chromatography paper followed by 10% trichloroacetic acid 
(TCA) rinses as described previously (19); (b) analyzing the reaction mixture with 
SDS PAGE, cutting out and determining the radioactive content of the bands 
corresponding to myosin light chain (20,000 Mr); (c) immunoprecipitating the 
reaction mixture with rabbit anti-human uterus myosin antiserum (31) whichhas 
been previously determined to cross-react with lymphocyte myosin light chain 
(9). Radioactivity was determined in each case by scintillation spectrometry 
following solubllization f the samples in Aquasol (New England Nuclear, 
Boston, MA). 
Negative Staining Procedures for 
Electron Microscopy 
For negative staining, three successive drops of either a solution f 0.1 M KCI, 
0.01 immidazole, pH 7.0, containing intact plasma membranes or a 1% NP-40 
insoluble fraction of the plasma membranes from ceils were addedto 4% 
Formvar-coated grids. Then three drops of I% uranyl acetate in water (pH 4.5) 
were apphed to the samples for 30 s and removed with filter paper (18). These 
negatively stained samples were examined in a Philips 300 electron microscope. 
RESULTS 
Double  immunof luorescence staining of prefixed lymphocytes  
reveals that the surface Con-A  receptors are general ly distr ib- 
uted uni formly over the surface o f  the ceils (Fig. I a) whi le 
intracellular myos in  l ight chain kinase is diffusely distr ibuted 
throughout  the cytoplasm (Fig. 1 b) under  the condit ions used. 
However,  when unfixed cells were induced to form capped 
structures (Fig. I c), the intracel lular MLCK was found to be 
concentrated under  the Con-A  cap (Fig. I d) .  I f  t r i f luoperazine 
was added to cells dur ing the capping reaction, then both the 
Con-A  surface receptors (Fig. 1 e) and the intracel lular MLCK 
(Fig. l f )  remained uni formly distr ibuted. The  results shown in 
Fig. l support  the content ion that ca lmodul in  may be related 
to the capping process (10, 22) and suggest hat this regulatory 
molecule and MLCK may be associated with the actomyosin-  
contain ing cytoskeleton required for Con-A  capping. 
Fig. 2 a shows a micrograph o f  the p lasma membrane  frac- 
t ion used in this study. The  fraction conta ined vesicles o f  
various sizes but no visual contaminat ion  by other membranous  
components  such as those f rom nuclei, mitochondr ia ,  or rough 
endoplasmic  ret iculum was apparent.  In addit ion, assays for 
Na+/K  + ATPase  and 5'-nucleot idase r vealed that the prepa-  
ration was enr iched for p lasma membranes  by 20-fold. Analysis 
FIGURE 2 Negative staining and SDS PAGE analysis of plasma membranes and NP-40 insoluble fraction of the plasma membranes 
from mouse T-lymphoma cells. (a) Isolated total plasma membranes without NP-40 treatment stained with uranyl acetate, x 
20,000. (b) Polypeptide composition of total plasma membranes stained by Coomassie Blue. (c) Polypeptide composition of N P-40 
insoluble (cytoskeleton) fraction of plasma membranes stained by Coomassie-Blue staining (myosin and actin together with a 
couple of other polypeptides are the major components in this cytoskeleton material). (d) NP-40 insoluble fractions cytoskeleton 
of the plasma membrane stained with uranyl acetate, x 40,000. Molecular weight markers used in the study are in daltons: myosin, 
200,000; fl-galactosidase, 130,000; lactoperoxidase, 78,000; BSA, 68,000; actin, 42,000; Con A, 25,000. 
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of this fraction by gel electrophoresis (Fig. 2 b) revealed at least 
30 bands detectable by Coomassie-Blue staining. An electron 
micrograph of the membrane-associated cytoskeletal complex 
(prepared by extraction of the plasma membranes with NP-40 
followed by centrifugation at 100,000 gay) is shown in Fig. 2 d. 
This fraction is composed primarily of 50-70-A actinlike fila- 
ment bundles (Fig. 2d). Indeed, the polypeptide composition 
of this fraction appears to be less complex (Fig. 2 c). In this 
case, the major proteins are actin (42,000), myosin heavy chain 
(200,000), and a doublet at 240,000-260,000 which presumably 
represents the subunits of the spectrinlike proteins described 
by Glenney et al. (17). 
MLCK has been identified as a 130,000-dalton polypeptide 
in several different ype of cells (3, 19) and can be phospho- 
rylated (2). Fig. 3 reveals an analysis of the protein components 
of both membrane and cytoskeletal fractions by autoradiogra- 
phy after metabolic labeling of lymphocytes with 32po4. At 
least 12 major phosphorylated polypeptides are evident in the 
total plasma membrane fraction (Fig. 3 a), but only four major 
phosphorylated polypeptides (at 220,000, 180,000, 130,000, and 
36,000) are present in the cytoskeletal fraction (Fig. 3 b). The 
130,000 protein in the plasma membrane has been identified 
as a phosphorylated form of MLCK by immunoprecipitation 
(Fig. 3 c) with a specific MLCK antibody. Similar results were 
obtained with the cytoskeleton fraction (data not shown). The 
specificity of the immunoprecipitation was established by the 
fact that an antiserum preabsorbed with MLCK precipitated 
TABLE I 
Assays for MLCK Activity 
pmol 32P-in- 
corporated/ 
Substrates Conditions min/mg MLC 
Skeletal muscle 
Smooth muscle 
Lymphocytes 
pCa 8.0 100 
pCa 4.0 + caimodulin 302 
pCa 4.0 + TFP 85 
3Ca 8.0 106 
~Ca 4.0 + ca lmodu l in  406 
3Ca 4.0 + TFP 100 
3Ca 8.0 186 
~Ca 4.0 + calmodulin 809 
~Ca 4.0 + TFP 70 
Enzyme reactions were carried out under various conditions such as (a) low 
Ca 2+ (pCa = 8.0, 10 -8 M, Ca2+); or (b) high Ca 2+ (pCa = 4.0, 10 -4 M, Ca 2÷) 
plus calomodulin; or (c) in the presence of 5 x I0 -s M trifluoperazine (TFP) 
(Stelazine) and high Ca 2+ (pCa = 4.0, 10 4 M, Ca 2+) using NP-40 insoluble 
(cytoskeleton) fraction from mouse T-lymphoma cells as crude MLCK sources. 
Reactions were initiated by the addition of -r'-32P-ATP and incubated for 5 
min at 30~C. The ability of lymphocyte MLCK to phosphorylate skeletal 
muscle, smooth muscle myosin light chains, and lymphocyte myosin light 
chain was measured according to the procedures described in Materials and 
Methods. In this particular case, the level of myosin light chain phosphoryl- 
ation was assayed by immunoprecipitating the MLCK reaction product with 
rabbit antimyosin followed by SDS PAGE analysis. The bands corresponding 
to myosin light chain (20,000 daltons) were cut out and radioactivity was 
determined using Aquasol and a liquid scintillation counter as described 
previously (9). Each number represents the average of three experiments with 
standard deviation less than ±5%. 
FIGURE 3 Autoradiograms of a2P-labeled proteins from mouse T- 
lymphoma cells. Cells were metabolically labeled with carrier free 
H332PO4 as described in Materials and Methods. (a) Total plasma 
membrane (in the absence of NP-40). (b) NP-40 insoluble (cyto- 
skeleton) fraction of plasma membranes. (c) Anti-MLCK immuno- 
precipitable from plasma membrane (similar results were obtained 
with the cytoskeleton fraction.) (d) Anti-MLCK-free (preabsorbed 
reagent)/(nonspecific) immunoprecipitates from plasma membrane 
(similar results were obtained with cytoskeleton fraction). Molecular 
weight markers used in this study were the same as those described 
in Fig. 2. 
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neither the 130,000 protein nor any of the other phosphorylated 
proteins (Fig. 3 d). 
Further confirmation of the presence of MLCK was obtained 
by carrying out functional assays for the enzyme as described 
in Materials and Methods. Table I shows that membrane- 
cytoskeletal fractions contain a Ca~+-calmodulin-activated (tri- 
fluoperazine-sensitive) MLCK activity. The enzyme is capable 
of phosphorylation f the endogenous lymphocyte light chains 
(Table I) as well as that of exogenously added light chains 
from smooth muscle (Table I) and skeletal muscle (Table I). 
The MLCK activity appears to be approximately 2-2.5-fold 
less when assayed with the exogenous myosin light chain as 
substrate. Two possible explanations for this reduction in ac- 
tivity could be either that the exogenous ubstrates are phos- 
phorylated and/or immunoprecipitated l ss efficiently than the 
endogenous lymphocyte myosin light chains or that the exog- 
enous substrate is competing with the endogenous substrate. 
However, regardless of the source of substrate, the specific 
activity of this enzyme is seven- to eightfold greater in the 
cytoskeletal fraction as compared to the total plasma mem- 
brane (data not shown). This enrichment of MLCK activity in 
the actomyosin complex provides additional evidence for the 
involvement of this enzyme in the regulation of lymphocyte 
receptor capping. 
DISCUSSION 
Both cytochemical and biochemical data now indicate that 
actomyosin-containing structures are closely associated with 
cap formation (4-6, 12, 16, 23). Such observations are compat- 
ible with the possibility that the force-generating mechanisms 
involved may be similar to those that occur during other motile 
events in smooth and nonmuscle cells (14). These mechanisms 
involve the activation of actomyosin ATPase by the phospho- 
rylation of the 20,000 Mr myosin light chain (1, 30). This 
activation is catalyzed by MLCK in a manner that requires 
Ca'~+-calmodulin (29). lntracellular concentrations of Ca 2+, 
calmodulin and ATP are all required for the capping of Con- 
A-receptors in lymphocytes (10). Calmodulin has been shown 
to co-cap with Con-A receptors (28) and myosin light chain 
phosphorylation ccurs during the capping event (9). We report 
here that the Final component of the putative contractile system, 
the MLCK, also co-caps with Con-A receptors and is, therefore, 
in the proper locale to catalyze the generation of force. 
MLCK was demonstrated to represent a component of the 
insoluble cytoskeletal network prepared by detergent treatment 
of lymphocyte plasma membranes. The enzyme was phospho- 
rylated metabolically in uncapped cells and immunoprecipi- 
tated by an antibody prepared against chick gizzard MLCK 
(19). For now the regulatory mechanism involved in the phos- 
phorylation of MLCK in intact lymphocytes i unknown. 
Consequently, under these conditions, the light chain of myosin 
does not appear to be phosphorylated asanalyzed by autora- 
diographic method (Fig. 3). These results are consistent with 
the demonstration that phosphorylation f the kinase lowers 
the activity of the enzyme (13). The activity of the enzyme was 
demonstrated using both endogenous lymphocyte myosin light 
chains and exogenously supplied substrate isolated from both 
smooth and skeletal muscle. The MLCK activity was both 
Ca 2+ and calmodulin dependent and was inhibited by the 
calmodulin-binding drug, trifluoperazine. By activity measure- 
ment, MLCK is enriched in the cytoskeletal preparation seven- 
to eightfold compared to the plasma membrane. In addition to 
MLCK, the 50-70-]~ Fdaments in the insoluble cytoskeletal 
material contained actin, myosin, and two high Mr proteins 
(240,000-260,000) that presumably represent the spectrinlike 
molecules described by Glenney et al. (17). These proteins bind 
both actin and calrnodulin and may therefore be involved in 
the cross-linking of specific components involved in cap for- 
mation. The energy required for such interactions could also 
be derived from actomyosin-catalyzed ATP hydrolysis in re- 
sponse to calmodulin-activated MLCK. Further evidence in 
support of the regulatory role of MLCK in Con-A cap forma- 
tion is presented elsewhere (22). 
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